Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ManevfiledCriticalManev
Priority to BG95724ApriorityCriticalpatent/BG95724A/en
Publication of BG95724ApublicationCriticalpatent/BG95724A/en
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Medicines Containing Plant Substances
(AREA)
Abstract
The medicament is used in neurology for the treatment of arthritis, paradontosis and stomatitis. It consists of 10-20% propolis 60-80% alcoholic extract purified from ballast and resinous substances, 4.5% camphor, 1.5% acidum salicilicum and 10% dimethylsulphoxidum.
BG95724A1992-01-041992-01-04Medicaments with analgetic, antiphlogestic and antibacterial effect for external use
BG95724A
(en)
Topically applicable compositions based on high molecular hyaluronic acid for the treatment of inflammation of the oral cavity, for its hygiene and cosmetic treatment
CONCOMITATING USE OF THE INSULIN-SIMILAR GROWTH FACTOR -I (IN THE FOLLOWING "FCI-I") AND THE BETA TRANSFORMING GROWTH FACTOR (IN THE "FCT-BETA" SUCCESSIVE) FOR THE MANUFACTURE OF A BONE REGENERATION MEDICATION Mammals
PROCESS FOR THE TREATMENT OR PROPHYLAXIS OF AN INFECTION ASSOCIATED WITH RETROVIRUS, USE, PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF AN INFECTION ASSOCIATED WITH RETROVIRUS, AND, COMPOUND